Qube Research & Technologies (QRT)
ZYNE

Qube Research & Technologies (QRT)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$127 – 4927
2023
Q3 		$127 Buy
+100
New +$87 ﹤0.01% 3754
2021
Q3 		– Sell
-23,079
Closed -$122K – 2937
2021
Q2 		$122K Buy
+23,079
New +$111K ﹤0.01% 1910
2021
Q1 		– Sell
-26,327
Closed -$87K – 2537
2020
Q4 		$87K Buy
26,327
+9,810
+59% +$37.3K ﹤0.01% 1658
2020
Q3 		$55K Sell
16,517
-6,904
-29% -$25.4K ﹤0.01% 1541
2020
Q2 		$79K Buy
+23,421
New +$111K ﹤0.01% 1545

Qube Research & Technologies (QRT)'s ZYNE Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 100 shares — an estimated $127 sold.

Qube Research & Technologies (QRT) first reported a position in ZYNE in Q2 2020 and held it in 5 quarters. The position peaked at $122K in Q2 2021. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 100 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $127.
  • Qube Research & Technologies (QRT) first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Zynerba Pharmaceuticals, Inc position peaked at $122K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.